New York State Legislature Recognizes Cancer Immunotherapy Awareness Month
NEW YORK (Jun. 5, 2013) – The State of New York has declared June “Cancer Immunotherapy Awareness Month” as a way to bring attention to cancer immunotherapy, a new class of cancer treatment that mobilizes the immune system to fight the disease and represents the most immediate hope for curing patients with any type of cancer.
The New York City-based nonprofit Cancer Research Institute (CRI), which is committed to developing immune system-based cancer treatments, started Cancer Immunotherapy Awareness Month because many members of the public are not aware of cancer immunotherapy’s ability to treat cancer and its potential to offer safer and more effective treatment options.
“I am thrilled to establish a partnership between the Cancer Research Institute and the New York State Legislature,” said Assemblyman Alec Brook-Krasny, who co-sponsored the resolution. “Cancer is one of the most important health issues facing New Yorkers today. It is my hope that by working together we can make great progress in highlighting the great efforts of the Cancer Research Institute and furthering the public’s awareness of new breakthroughs in potentially life-saving treatments. We hope that by raising awareness of their research in immunology, they will not only be able to save lives but become a valuable partner in the health and safety of New York State.”
Cancer Immunotherapy Awareness Month will raise awareness of the sea change in cancer research and treatment, and enlist public support in helping accelerate development of immunotherapies for patients with all types of cancer.
The Assembly resolution was sponsored by Assemblyman Alec Brook-Krasny (D-46th), and the New York Senate resolution was sponsored by Sen. Diane Savino (D-23rd). Mayor Michael Bloomberg and New York City have joined the state legislature and Gov. Andrew Cuomo in recognizing Cancer Immunotherapy Awareness Month.
"Immunotherapy is fast becoming one of the most pioneering advancements for cancer treatment since the early beginning of chemotherapy in the 1940s. So I am pleased to join Assemblyman Brook-Krasny and sponsor this resolution proclaiming June 2013 as Cancer Immunotherapy Awareness Month in the State of New York,” Sen. Savino said.
During the month of June, the Cancer Research Institute is hosting a series of webinars each week that are free and open to the public. Audience participants may submit questions for the experts in a moderated Q&A session following the presentation.
June 7 is “Wear White for a Cure Day” in support of efforts to speed cancer immunotherapy development. Participants can register for the event through the CRI website or via Facebook. Donors and fundraisers for the event will receive a wristband and T-shirt featuring CRI’s “I’Mmunotherapy and I’m curing cancer” slogan.
“For 60 years, CRI has remained steadfast in its dedication to realizing immunotherapy’s potential to treat and cure cancer,” said Jill O’Donnell-Tormey, Ph.D., chief executive officer and director of scientific affairs at the Cancer Research Institute. “Because of this work, today safe and powerful new immune-based treatment options are finally available, and we are dedicated to increasing awareness and support to bring them to more patients sooner.”
To register for the webinars and for the June 7 “Wear White for a Cure Day” event, visit www.cancerresearch.org/fightwithwhite.
About the Cancer Research Institute
The Cancer Research Institute (CRI), established in 1953, is the world’s leading nonprofit organization dedicated exclusively to transforming cancer patient care by advancing scientific efforts to develop new and effective immune system-based strategies to prevent, diagnose, treat, and eventually cure all cancers. Guided by a world-renowned Scientific Advisory Council that includes three Nobel laureates and 26 members of the National Academy of Sciences, CRI has invested $336 million in support of research conducted by immunologists and tumor immunologists at the world’s leading medical centers and universities, and has contributed to many of the key scientific advances that demonstrate the potential for immunotherapy to change the face of cancer treatment. To learn more, go to www.cancerresearch.org